Valuation: Kamada Ltd.

Market Cap 1.23B 0 410M 359M 331M 310M 581M 38.64B 593M 3.98B 1.54B 19.1B 1.54B 1.5B 66.22B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.23B 0 410M 359M 331M 310M 581M 38.64B 593M 3.98B 1.54B 19.1B 1.54B 1.5B 66.22B EV / Sales 2026 *
2.1x
EV / Sales 2027 * 1.91x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 75 13/12/1990
Chairman 77 07/03/2013
Chairman 55 12/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.04% - - 410M
+2.06%+3.76%+21.48%-11.62% 64.39B
+0.74%+3.52%+51.88%+225.16% 56.12B
-3.10%+34.30%+34.30%+34.30% 40.54B
-2.36%-1.25%-50.98%-58.84% 37.98B
+6.97%+9.89%+71.34%-23.65% 31.89B
+12.59%+5.18%+147.68%-44.25% 26.69B
+5.78%+15.81%+66.37%+84.42% 22.73B
-1.25%-1.31%-2.84%+151.34% 16.66B
-0.81%+5.91%+63.81%+125.65% 16.6B
Average +2.01%+4.32%+44.78%+53.61% 34.84B
Weighted average by Cap. +1.96%+4.11%+39.81%+49.85%

Financials

2026 *2027 *
Net sales 585M 0 195M 171M 158M 147M 277M 18.39B 282M 1.89B 733M 9.09B 732M 716M 31.51B 642M 0 214M 188M 173M 162M 304M 20.19B 310M 2.08B 804M 9.98B 803M 786M 34.59B
Net income 72.01M 0 24.01M 21.05M 19.4M 18.16M 34.06M 2.26B 34.77M 233M 90.24M 1.12B 90.14M 88.18M 3.88B 104M 0 34.55M 30.29M 27.92M 26.14M 49.02M 3.26B 50.04M 336M 130M 1.61B 130M 127M 5.59B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
-
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-